Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM) is a Healthcare stock tracked by StreetAlpha. CTNM reports earnings on Thu, Oct 29, 2026. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in CTNM, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 15 | Jones Trading | Target raised | Buy | — |
| Oct 14 | Baird | Downgrade | Hold | — |
| Sep 28 | Morgan Stanley | Maintained | Hold | — |
| Sep 15 | Jones Trading | Maintained | Buy | — |
| Sep 15 | Baird | Maintained | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTNM is in one of them and how their past CTNM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CTNM in an article yet. Here's the latest on the wider market.